Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Robust dysregulation of gene expression in substantia nigra and striatum in Parkinson's disease.

Miller RM, Kiser GL, Kaysser-Kranich TM, Lockner RJ, Palaniappan C, Federoff HJ.

Neurobiol Dis. 2006 Feb;21(2):305-13. Epub 2005 Sep 6.

PMID:
16143538
2.

Performance evaluation of commercial short-oligonucleotide microarrays and the impact of noise in making cross-platform correlations.

Shippy R, Sendera TJ, Lockner R, Palaniappan C, Kaysser-Kranich T, Watts G, Alsobrook J.

BMC Genomics. 2004 Sep 2;5:61.

3.

Oligodeoxyribonucleotide probe accessibility on a three-dimensional DNA microarray surface and the effect of hybridization time on the accuracy of expression ratios.

Dorris DR, Nguyen A, Gieser L, Lockner R, Lublinsky A, Patterson M, Touma E, Sendera TJ, Elghanian R, Mazumder A.

BMC Biotechnol. 2003 Jun 11;3:6. Epub 2003 Jun 11.

4.

An assessment of Motorola CodeLink microarray performance for gene expression profiling applications.

Ramakrishnan R, Dorris D, Lublinsky A, Nguyen A, Domanus M, Prokhorova A, Gieser L, Touma E, Lockner R, Tata M, Zhu X, Patterson M, Shippy R, Sendera TJ, Mazumder A.

Nucleic Acids Res. 2002 Apr 1;30(7):e30.

5.

The hairpin ribozyme. Discovery, mechanism, and development for gene therapy.

Shippy R, Lockner R, Farnsworth M, Hampel A.

Mol Biotechnol. 1999 Aug;12(1):117-29. Review.

PMID:
10554775
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk